Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.235
-0.025 (-1.98%)
Nov 21, 2024, 3:54 PM EST - Market closed
Century Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$13.00
Upside
+952.63%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +790.69% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +304.86% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +628.74% | Aug 15, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +871.66% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +790.69% | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +790.69% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +628.74% | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +952.63% | Mar 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +1,843.32% | Mar 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +952.63% | Dec 7, 2023 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $28 → $5 | Buy → Hold | Downgrades | $28 → $5 | +304.86% | Aug 28, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $10 | Buy | Maintains | $14 → $10 | +709.72% | Aug 10, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $13 | Strong Buy | Maintains | $17 → $13 | +952.63% | Aug 10, 2023 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +1,195.55% | Aug 10, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $19 → $17 | Strong Buy | Maintains | $19 → $17 | +1,276.52% | Aug 10, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +1,276.52% | May 12, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.